IRIS
TARAMASSO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.616
Totale 8.616
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.616
Totale 8.616
Salva come PNG Salva come JPEG
Città #
Genova 5.419
Rapallo 1.163
Genoa 1.094
Vado Ligure 896
Bordighera 44
Totale 8.616
Salva come PNG Salva come JPEG
Nome #
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 245
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? 185
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 170
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 167
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 159
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 158
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 145
Bloodstream infections in patients living with HIV in the modern cART era 138
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 137
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 136
Will new antimicrobials overcome resistance among Gram-negatives? 124
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 118
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy? 117
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 116
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 116
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 110
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 109
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 109
Bedaquiline: A new hope for shorter and better anti-tuberculosis regimens 109
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 107
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 107
AUMENTO DEGLI INDICI DI CITOLISI EPATICA NEI SOGGETTI CON INFEZIONE DA HIV CHE AVVIANO LA PRIMA LINEA DI TRATTAMENTO ANTIRETROVIRALE: STUDIO OSSERVAZIONALE DI COORTE 105
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 102
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing 101
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy 101
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 100
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? 100
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 99
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 97
Pineal Germinoma in a Child with Interferon-γ Receptor 1 Deficiency. Case Report and Literature Review 93
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. 93
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 92
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients 92
Onychomadesis in a male patient with secondary syphilis 91
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 91
Weight gain: A possible side effect of all antiretrovirals 91
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 91
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 89
Factors associated with hospital admission for COVID-19 in HIV patients 88
Is it time to re-think the use of etravirine in patients with available genotypic resistance test? 87
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 86
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia 85
Bloodstream infections in critically ill patients with COVID-19 85
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes 83
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? 83
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 83
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 82
Treatment of hepatitis C virus genotype 4 in the DAA era 82
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 80
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 80
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment 80
Co-infezione HIV/HCV e malattia renale: un binomio “scindibile” 80
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 79
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 78
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 77
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 74
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 73
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 72
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients 71
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 71
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 71
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations. Results from a large observational study 69
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 69
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 67
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 67
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 66
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 64
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 64
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency 62
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 62
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 61
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 61
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 56
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 56
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 55
Bloodstream infections in HIV-infected patients 54
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 54
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 53
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 52
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 49
null 49
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 49
Duration of isolation and precautions in immunocompromised patients with COVID-19 48
Injectable Antiretroviral Drugs: Back to the Future 48
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 47
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 46
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 45
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 43
Darunavir e incremento del peso corporeo: due diversi booster, stessi risultati 42
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 41
Real-World Analysis of Survival and Clinical Events in a Cohort of Italian Perinatally HIV-1 Infected Children From 2001 to 2018 41
Role of raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents 38
COVID-19: Some clinical questions after the first 4 months 37
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 36
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 36
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 35
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 33
Functional tricuspid regurgitation: The increasing clinical importance of the "forgotten valve" 33
The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen 32
Aspetti medico sanitari, area infettivologica. In: Being Positive Strategie e Linguaggi per la comunicazione dell'HIV 30
Totale 8.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.679
article - articoli 35.527
book - libri 0
conference - conferenze 723
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 138
Totale 73.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.798 0 0 0 0 192 233 342 207 231 326 196 71
2020/20211.332 50 137 253 109 84 84 75 120 73 130 65 152
2021/20221.201 48 39 59 138 51 98 57 270 105 126 50 160
2022/20231.434 119 115 11 130 175 195 64 105 209 109 178 24
2023/2024922 39 94 13 111 68 146 71 64 43 25 98 150
2024/2025939 91 200 91 188 369 0 0 0 0 0 0 0
Totale 8.973